Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$205.00
1.680.83%
At Close: -
$205.00
00.00%
After Hours: 4:05 PM EDT
15 minutes delayed
Comments
Loading...
Overview Rating
Speculative
Biogen (NASDAQ:BIIB) Stock Quotes, Forecast and News Summary
Biogen Stock (NASDAQ: BIIB) stock price, news, charts, stock research, profile.
| Open | $204.50 |
| Close | $205.00 |
| Volume / Avg. | 1.13M / 1.03M |
| Day Range | $202.13 - $205.54 |
| 52 Wk Range | 189.44 - 270.50 |
| Market Cap | $29.86B |
| P/E Ratio | 25.63 |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 44 |
| Short Interest | 2.12% |
| Days to Cover | 2.36 |
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Biogen Inc
Sector
Health Care
Industry
Biotechnology
Biogen and Idec merged in 2003, combining forces to market Biogen's multiple sclerosis drug Avonex a...
Show More
Compare
EPS better than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS better than industry
FAQ
How do I buy Biogen (BIIB) stock?
You can purchase shares of Biogen (NASDAQ:BIIB) through any online brokerage.
Who are Biogen (BIIB) competitors?
Other companies in Biogen’s space includes: Legend Biotech (NASDAQ:LEGN), Sarepta Therapeutics (NASDAQ:SRPT), Exact Sciences (NASDAQ:EXAS), Neurocrine Biosciences (NASDAQ:NBIX) and Roivant Sciences (NASDAQ:ROIV).
What is the forecast, or price target, for Biogen (BIIB) stock?
Biogen has a consensus price target of $278.79.
What is the current price for Biogen (BIIB)?
The stock price for Biogen (NASDAQ: BIIB) is $205 last updated August 23, 2024 at 4:05 PM EDT.
Does Biogen (BIIB) pay a dividend?
There are no upcoming dividends for Biogen.
When is Biogen (NASDAQ:BIIB) reporting earnings?
Biogen’s Q3 earnings are confirmed for Wednesday, November 6, 2024.
Is Biogen (BIIB) going to split?
There is no upcoming split for Biogen.
What sector and industry does Biogen (BIIB) operate in?
Biogen is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.